Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(17)
•••
Comment by alphaseeking001on Apr 12, 2019 2:49pm
138 Views
Post# 29620250

RE:RE:RE:RE:development

RE:RE:RE:RE:developmentI seriously hope you are wrong, no offence intended.  I do think the company is in a "prove you have monotherapy effect" mode now though.  Until we see the proof, hopefully in June, I don't think we'll see much happen here.  Like I've stated before though, for those of us who have met with them the past few months, I do feel as if they are on to something here and I don't feel they are completely incompetent. That being said, I seriously hope I'm not proved wrong.  
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities